Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Recher

Showing results (41-50 of 122) with videos related to

Pageof 13
Sort By:
Open Forum Infectious Diseases|October 30, 2019
Syphilis Reactivates Latent Epstein-Barr Virus Reservoir via Toll-Like Receptor 2 and B-Cell Receptor ActivationJulia R Hirsiger, Philipp S Fuchs, Peter Häusermann, et al.
The Journal of Experimental Medicine|August 2, 2006
Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spreadLars Hangartner, Raphaël M Zellweger, Mattia Giobbi, et al.
European Journal of Immunology|February 23, 2005
Inverse correlation between IL-7 receptor expression and CD8 T cell exhaustion during persistent antigen stimulationKarl S Lang, Mike Recher, Alexander A Navarini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2005
Requirement for neutralizing antibodies to control bone marrow transplantation-associated persistent viral infection and to reduce immunopathologyKarl S Lang, Mike Recher, Alexander A Navarini, et al.
Plos Pathogens|November 9, 2013
Usp18 driven enforced viral replication in dendritic cells contributes to break of immunological tolerance in autoimmune diabetesNadine Honke, Namir Shaabani, Dong-Er Zhang, et al.
European Journal of Immunology|November 15, 2002
Role of ICOS versus CD28 in antiviral immunityEdward M Bertram, Anna Tafuri, Arda Shahinian, et al.
Blood|December 13, 2016
Trametinib after disease reactivation under dabrafenib in Erdheim-Chester disease with both <i>BRAF</i> and <i>KRAS</i> mutationsThierry M Nordmann, Freimut D Juengling, Mike Recher, et al.
Anticancer Research|August 30, 2022
Treosulfan-based Reduced-intensity Allogeneic Hematopoietic Cell Transplantation in Adults With Primary Immunodeficiency: A Case SeriesVera Dalla Via, Anne Stelmes, Mike Recher, et al.
PNAS Nexus|November 11, 2025
Increase of Inhibitory Siglec receptors on T cells mitigates severe immune reactions during acute viral infectionsNatalia Rodrigues Mantuano, Anne Bärenwaldt, Mirza Sarcevic, et al.
Clinical Endocrinology|August 24, 2017
Iron metabolism in patients with Graves' hyperthyroidismStefan Fischli, Viktor von Wyl, Michael Trummler, et al.
Pageof 13

Showing results (41-50 of 122) with videos related to

Sort By:
Pageof 13
Open Forum Infectious Diseases|October 30, 2019
Syphilis Reactivates Latent Epstein-Barr Virus Reservoir via Toll-Like Receptor 2 and B-Cell Receptor ActivationJulia R Hirsiger, Philipp S Fuchs, Peter Häusermann, et al.
The Journal of Experimental Medicine|August 2, 2006
Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spreadLars Hangartner, Raphaël M Zellweger, Mattia Giobbi, et al.
European Journal of Immunology|February 23, 2005
Inverse correlation between IL-7 receptor expression and CD8 T cell exhaustion during persistent antigen stimulationKarl S Lang, Mike Recher, Alexander A Navarini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2005
Requirement for neutralizing antibodies to control bone marrow transplantation-associated persistent viral infection and to reduce immunopathologyKarl S Lang, Mike Recher, Alexander A Navarini, et al.
Plos Pathogens|November 9, 2013
Usp18 driven enforced viral replication in dendritic cells contributes to break of immunological tolerance in autoimmune diabetesNadine Honke, Namir Shaabani, Dong-Er Zhang, et al.
European Journal of Immunology|November 15, 2002
Role of ICOS versus CD28 in antiviral immunityEdward M Bertram, Anna Tafuri, Arda Shahinian, et al.
Blood|December 13, 2016
Trametinib after disease reactivation under dabrafenib in Erdheim-Chester disease with both <i>BRAF</i> and <i>KRAS</i> mutationsThierry M Nordmann, Freimut D Juengling, Mike Recher, et al.
Anticancer Research|August 30, 2022
Treosulfan-based Reduced-intensity Allogeneic Hematopoietic Cell Transplantation in Adults With Primary Immunodeficiency: A Case SeriesVera Dalla Via, Anne Stelmes, Mike Recher, et al.
PNAS Nexus|November 11, 2025
Increase of Inhibitory Siglec receptors on T cells mitigates severe immune reactions during acute viral infectionsNatalia Rodrigues Mantuano, Anne Bärenwaldt, Mirza Sarcevic, et al.
Clinical Endocrinology|August 24, 2017
Iron metabolism in patients with Graves' hyperthyroidismStefan Fischli, Viktor von Wyl, Michael Trummler, et al.
Pageof 13